Nierenzellkarzinom: Everolimus neuer Standard nach TKI-Versagen
Crossref DOI link: https://doi.org/10.1007/BF03369383
Published Online: 2016-07-01
Published Print: 2010-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
